Only Hoover's leverages journalistic capabilities to transform company research into easy-to-read, entertaining content.
Company Research: Keryx Biopharmaceuticals Corporate Information
Contact this company: 212-531-5965
Need in-depth company research? Need comprehensive Keryx Biopharmaceuticals corporate information? Similar to the company research that Hoover's provides for all public companies, the Keryx Biopharmaceuticals profile created by Hoover's in-house editorial team includes full financials, supplemented with company research on its operations, ownership, and past strategies. The Keryx Biopharmaceuticals Overview and History provide an historical perspective of how Keryx Biopharmaceuticals has evolved.
Keryx Biopharmaceuticals Corporate Information
Drugs are a life-or-death business for Keryx Biopharmaceuticals. The company specializes in developing treatments for life-threatening ailments, such as cancer and kidney disease. Its lead candidate is Zerenex, a compound that may reduce high phosphate levels in patients with end-stage renal disease. The company is also developing KRX-0401 (also known...
View more Keryx Biopharmaceuticals company research.
Buy the complete Hoover's company report on Keryx Biopharmaceuticals
Hoover's supplements secondary sources with primary research conducted by an in-house editorial team. Keryx Biopharmaceuticals corporate information also includes details on Keryx Biopharmaceuticals executives, products and operations, and family tree. With Hoover's, you can take advantage of proprietary company research on more than 28 million businesses.
See how you can view all of Hoover's company research for Keryx Biopharmaceuticals.
